Aehr Test Systems (NASDAQ:AEHR) Updates Q3 2024 Earnings Guidance

Aehr Test Systems (NASDAQ:AEHR) issued an update on its third quarter 2024 earnings guidance on Monday morning. The company provided earnings per share guidance of -0.040–0.030 for the period, compared to the consensus earnings per share estimate of 0.130. The company issued revenue guidance of $7.6 million-$7.6 million, compared to the consensus revenue estimate of $14.3 million. Aehr Test Systems also updated its FY 2024 guidance to 0.480- EPS.

Aehr Test Systems Price Performance

Shares of AEHR traded down $3.33 during mid-day trading on Monday, reaching $11.33. The company had a trading volume of 7,849,961 shares, compared to its average volume of 1,732,461. Aehr Test Systems has a twelve month low of $10.53 and a twelve month high of $54.10. The company’s 50-day moving average is $16.25 and its 200-day moving average is $26.15. The company has a market capitalization of $326.87 million, a P/E ratio of 15.55 and a beta of 2.01.

Aehr Test Systems (NASDAQ:AEHR) last issued its earnings results on Tuesday, January 9th. The semiconductor company reported $0.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.16 by $0.04. The business had revenue of $21.43 million during the quarter, compared to analysts’ expectations of $20.10 million. Aehr Test Systems had a return on equity of 26.97% and a net margin of 25.76%. As a group, equities analysts expect that Aehr Test Systems will post 0.72 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on AEHR shares. StockNews.com upgraded Aehr Test Systems from a sell rating to a hold rating in a research report on Friday, January 19th. William Blair restated a market perform rating on shares of Aehr Test Systems in a research report on Monday.

Insider Buying and Selling at Aehr Test Systems

In other Aehr Test Systems news, CEO Gayn Erickson sold 4,871 shares of the stock in a transaction on Thursday, January 18th. The stock was sold at an average price of $17.39, for a total value of $84,706.69. Following the transaction, the chief executive officer now directly owns 427,935 shares in the company, valued at approximately $7,441,789.65. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other Aehr Test Systems news, VP Avijit K. Ray-Chaudhuri acquired 3,000 shares of the company’s stock in a transaction that occurred on Friday, January 12th. The shares were acquired at an average price of $17.87 per share, with a total value of $53,610.00. Following the purchase, the vice president now owns 9,719 shares of the company’s stock, valued at approximately $173,678.53. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Gayn Erickson sold 4,871 shares of the firm’s stock in a transaction on Thursday, January 18th. The stock was sold at an average price of $17.39, for a total value of $84,706.69. Following the sale, the chief executive officer now directly owns 427,935 shares in the company, valued at approximately $7,441,789.65. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 8,738 shares of company stock worth $151,723. Insiders own 6.30% of the company’s stock.

Institutional Trading of Aehr Test Systems

Hedge funds have recently added to or reduced their stakes in the business. BlackRock Inc. increased its position in shares of Aehr Test Systems by 253.4% in the second quarter. BlackRock Inc. now owns 1,830,555 shares of the semiconductor company’s stock valued at $75,510,000 after acquiring an additional 1,312,565 shares during the last quarter. Vanguard Group Inc. raised its position in shares of Aehr Test Systems by 2.6% in the fourth quarter. Vanguard Group Inc. now owns 1,508,759 shares of the semiconductor company’s stock valued at $40,027,000 after buying an additional 38,384 shares in the last quarter. Ameriprise Financial Inc. acquired a new stake in shares of Aehr Test Systems in the first quarter valued at approximately $42,623,000. Oberweis Asset Management Inc. raised its position in shares of Aehr Test Systems by 19.9% in the fourth quarter. Oberweis Asset Management Inc. now owns 1,091,202 shares of the semiconductor company’s stock valued at $28,950,000 after buying an additional 181,094 shares in the last quarter. Finally, Renaissance Technologies LLC raised its position in shares of Aehr Test Systems by 49.4% in the first quarter. Renaissance Technologies LLC now owns 766,800 shares of the semiconductor company’s stock valued at $7,791,000 after buying an additional 253,700 shares in the last quarter. Institutional investors and hedge funds own 69.69% of the company’s stock.

About Aehr Test Systems

Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices.